ET
STOK icon

Entropy Technologies’s Stoke Therapeutics STOK Stock Holding History

Entropy Technologies’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+7,680
New +$246K 0.01% 828
2026
Q1 		– Sell
-11,764
Closed -$373K – 1147
2025
Q4 		$373K Buy
+11,764
New +$354K 0.02% 640

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Entropy Technologies's STOK Position: Q2 2026 in Review

Entropy Technologies opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 7,680 shares worth $251K. The stake represents 0.01% of the portfolio and ranks #828 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in STOK as recently as Q4 2025.

Entropy Technologies first reported a position in STOK in Q4 2025 and has held it in 2 quarters since. The position peaked at $373K in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Entropy Technologies held 7,680 shares of Stoke Therapeutics worth $251K as of Q2 2026.
  • Stoke Therapeutics was a new Entropy Technologies position in Q2 2026.
  • Stoke Therapeutics made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #828 holding.
  • Entropy Technologies first reported a position in Stoke Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Entropy Technologies's Stoke Therapeutics position peaked at $373K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.